GLP-1 drug exenatide shows no benefit for Parkinson’s in new study

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson’s, finds a new study led by UCL researchers.

Customized diets: The future of disease management revealed in gut study

The interactions between individual diets and the gut microbiome.

September 13, 2023

New technique enables high-resolution analysis of DNA

Function and form are deeply intertwined in biology. Knowing how organisms grow, adapt and reproduce requires understanding their physical structures. Hence the transformative power of

August 4, 2023

US trade body again delays decision on Apple-Masimo patent dispute

Dive Brief: The U.S. International Trade Commission (ITC) has delayed a decision on a patent dispute between Apple and Masimo until October. A final vote

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.